Terns Pharmaceuticals
Latest round
- Series C
Last raised
- Dec 2020
Total raised
- $208M
Investors
- 8
About Terns Pharmaceuticals
Founded in 2017 and based in California, US, Terns Pharmaceuticals, Inc. operates as a biotechnology company that develops treatments for patients with chronic liver diseases. The company was founded by CEO Senthil Sundaram.5 million shares at USD 17 per share on the NASDAQ. Terns Pharmaceuticals operates as a clinical-stage biopharmaceutical company that develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ program called TERN-101 a liver-distributed, nonsteroidal, non-bile acid FXR agonist that has demonstrated a differentiated tolerability profile and improved target engagement due to its sustained FXR activation in the liver but only transient intestinal FXR activation. Terns Pharmaceuticals plans to list on the Nasdaq global select market under the ticker symbol TERN.
Who invested in Terns Pharmaceuticals
8 investors across 3 rounds
See all investors in Terns Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Terns Pharmaceuticals
Who invested in Terns Pharmaceuticals?
Terns Pharmaceuticals has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Terns Pharmaceuticals raised?
Terns Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Terns Pharmaceuticals last raise money?
Terns Pharmaceuticals's most recent round on record is a Series C, in Dec 2020.
What does Terns Pharmaceuticals do?
Founded in 2017 and based in California, US, Terns Pharmaceuticals, Inc.
Where is Terns Pharmaceuticals headquartered?
Terns Pharmaceuticals is headquartered in Foster City, US.
Which VCs invest in companies like Terns Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Terns Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Terns Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.